# Safety and Efficacy of Sublingual Immunotherapy for Allergic Rhinitis Due to Artemisia Annua

> **NCT03990272** · PHASE3 · COMPLETED · sponsor: **Beijing Tongren Hospital** · enrollment: 702 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** AIT drops
- **DRUG:** placebo drops

## Key facts

- **NCT ID:** NCT03990272
- **Lead sponsor:** Beijing Tongren Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-20
- **Primary completion:** 2017-10-22
- **Final completion:** 2017-10-30
- **Target enrollment:** 702 (ACTUAL)
- **Last updated:** 2020-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03990272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03990272, "Safety and Efficacy of Sublingual Immunotherapy for Allergic Rhinitis Due to Artemisia Annua". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03990272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*